Other Patient-Focused Efforts at FDA and Patient Listening Session Resources
The FDA Public Engagement Staff leads the Patient Listening Session program and will coordinate internal review of Patient Listening Session requests on a quarterly schedule as follows:
- Requests submitted January 1 – March 31 will be reviewed starting April 1
- Requests submitted April 1 – June 30 will be reviewed starting July 1
- Requests submitted July 1 – September 30 will be reviewed starting Oct 1
- Requests submitted Oct 1 – December 31 will be reviewed starting January 1
Other Patient-Focused Efforts at FDA
- FDA Patient Engagement Opportunities
- Center for Drug Evaluation and Research (CDER) Patient-Focused Drug Development
- Oncology Center of Excellence
- Center for Biologics Evaluation and Research (CBER) Patient Engagement
- Center for Devices and Radiological Health (CDRH) Patient Engagement
- CDRH Patient Preference Initiative
- FDA Rare Disease Innovation Hub
Additional resources
- FDA staff manual guide: FDA Patient Listening Sessions
- FDA engages patient communities through listening session initiative
- How the FDA is Putting the Patient Voice at the Forefront of Gene Therapy Clinical Trials for Hemophilia
- National Organization for Rare Disorders (NORD) External Link Disclaimer
- Reagan-Udall Foundation for the FDA External Link Disclaimer